FDA Bans Oscar Bobo for Five Years Over Mislabeled Drug Imports
Published Date: 5/15/2026
Notice
Summary
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He ignored the chance to defend himself, so the ban started on May 15, 2026. This means no drug imports from him for a while, but he can apply to end the ban anytime if he meets FDA’s conditions.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
Five‑Year Drug Import Debarment
Oscar Bobo is banned for 5 years from importing or offering to import any drug into the United States, effective May 15, 2026. FDA found that between April 5, 2019 and September 3, 2024 he imported or offered for import 8 parcels containing 10 products (5,970 tablets) that were misbranded, and he waived his right to a hearing by not responding by March 25, 2026. Mr. Bobo may apply at any time for termination of the debarment under section 306(d)(1) of the FD&C Act by submitting an application as directed in the notice.
Importing for Debarred Person Is Prohibited
During Mr. Bobo's 5-year debarment, importing or offering for import any drug "by, with the assistance of, or at the direction of" Oscar Bobo is a prohibited act under section 301(cc) of the FD&C Act, effective May 15, 2026. That prohibition applies to conduct during the debarment period and may expose anyone who assists or acts at his direction to enforcement consequences.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2026-09766, Notice of Final Federal Agency Actions on Proposed Transportation Project in State Florida
Florida’s Department of Transportation is ready to upgrade Clearlake Road from a two-lane street to a safer, four-lane road with a cool new roundabout and bike-friendly paths on both sides. If you want to challenge these changes, you’ve got until October 13, 2026, to speak up. This project promises smoother traffic and better travel for everyone in the area!
Next: 2026-09768, Notice of Determinations; Culturally Significant Objects Being Imported for Exhibition-Determinations: “Tarot! Renaissance Roots, Modern Visions” Exhibition
The U.S. government has approved special Tarot art pieces from other countries to be shown temporarily at The Morgan Library & Museum in New York and possibly other places. This means the exhibition is officially recognized as important to culture and the nation. No costs or deadlines affect the public, but the show highlights cool Renaissance and modern Tarot art for everyone to enjoy.